Process for preparing formulations for gastrointestinal-targeted therapies
The present invention provides a process for preparing enterically-coated lyospheres comprising a therapeutic agent comprising: a.) providing lyospheres comprising the therapeutic agent; b.) coating said lyospheres with an enteric polymer coating composition; and c.) isolating said enterically-coated lyospheres. In other embodiments, the invention provides dosage forms comprising a lyosphere comprising an effective amount of a therapeutic agent and an enteric polymer coating. In some embodiments, the therapeutic agent in the process or dosage form is a polypeptide, a protein, a peptide, a lipopeptide, a glycoprotein, a fusion protein, a protein conjugate, a cytokine, an enzyme, an antibody, an oligonucleotide, a vaccine vector, small molecule, a live virus, an inactivated virus, a virus-like particle, a viral protein subunit, an adjuvant, microbiome, a prebiotic, a probiotic, or an ectobiotic. In some embodiments of the present invention, after oral administration the dosage forms containing the enterically-coated lyospheres provide a method of delivering a therapeutic agent to the ileum, ileo-caecal junction, colon or a combination thereof in a subject.
1. A process for preparing enterically-coated lyospheres comprising a therapeutic agent comprising:
a.) providing lyospheres comprising the therapeutic agent;
b.) coating said lyospheres with an enteric polymer coating composition; and
c.) isolating said enterically-coated lyospheres;
wherein said lyospheres in step a.) are prepared by:
mixing the therapeutic agent, a sugar, and a binding-gel forming agent in an aqueous medium to form an aqueous medium mixture;
segregating the aqueous medium mixture into unitary volumes;
freezing said unitary volumes to form unitary forms; and
separating water from said unitary forms to yield the lyospheres.
2. The process of claim 1 , wherein in step b.) the enteric polymer coating composition comprises an anionic polymer selected from an acrylic or methacrylic acid copolymer, a carboxylic acid-containing cellulosic polymer, a carboxylic acid-containing polyvinyl acetate copolymer, or shellac.
3. The process of the claim 2 , wherein
the acrylic or methacrylic acid copolymer is poly(methacrylic acid, methyl methacrylate) 1:1, poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, ethyl acrylate) 1:1; or poly(methyl acrylate, methyl methacrylate, methacrylic acid) 7:3:1
the carboxylic acid-containing cellulosic polymer is hydroxypropylmethyl cellulose phthalate, cellulose acetate phthalate (CAP), cellulose acetate trimellitate, hydroxypropylmethyl cellulose succinate; and
the carboxylic acid-containing polyvinyl acetate copolymer is polyvinyl acetate phthalate.
4. The process of claim 1 , wherein step b.) comprises spray- or dip-coating the lyospheres with the enteric polymer coating composition.
5. The process of claim 4 , wherein said coating step b.) comprises spray-coating the lyospheres with the enteric polymer coating composition.
6. The process of claim 5 , wherein said spray-coating is bottom spray-coating, tangential spray-coating, or pan-coating.
7. The process of claim 6 , wherein said enteric polymer coating composition is dispersed in an aqueous medium.
8. The process of claim 1 , wherein the coating and isolating steps result in enterically-coated lyospheres having a weight gain of at least 10 wt. %.
9. The process of claim 1 , wherein said segregating, freezing, and separating steps comprise:
segregating the aqueous medium mixture into unitary volumes on a pre-cooled flat surface of a solid element to form the unitary forms;
removing the unitary forms from the flat surface, and
drying the unitary forms under conduction- or radiant-dominant drying to yield said lyospheres.
10. The process of claim 1 , wherein said segregating, freezing, and separating steps comprise:
filling cavities of a solid element with the aqueous medium mixture;
freezing the aqueous medium mixture while present in the cavities by extracting heat from the aqueous medium mixture through a cavity wall by conduction to form the unitary forms;
removing the unitary forms from the cavity, and
drying the unitary forms in a vacuum to obtain the lyospheres.
11. The process of claim 1 , wherein said binding-gel forming agent is a cellulosic polymer, polyvinylpyrollidone, starch, gelatin, polyethylene glycol, wax, a natural gum, a synthetic gum, or a combination thereof.
12. The process of claim 11 , wherein said binding-gel forming agent is a cellulosic polymer selected from hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methyl cellulose, microcrystalline cellulose, ethyl cellulose, or a combination thereof.
13. The process of claim 12 , wherein said binding-gel forming agent is hydroxypropylmethyl cellulose.
14. The process of claim 1 , wherein the therapeutic agent which is a polypeptide, a protein, a peptide, a lipopeptide, a glycoprotein, a fusion protein, a protein conjugate, a cytokine, an enzyme, an antibody, an oligonucleotide, a vaccine vector, small molecule, a live virus, an inactivated virus, a virus-like particle, a viral protein subunit, an adjuvant, microbiome, a prebiotic, probiotic, or an ectobiotic.
15. The process of claim 1 , wherein said binding-gel forming agent comprises from 2 to 40% w/v of the aqueous medium mixture.
16. The process of claim 1 , wherein said sugar is trehalose, sucrose, glucose, galactose, maltose, lactose, raffinose, fructose, saccharose, mannitol, sorbitol, xylitol, or a combination thereof.
17. The process of claim 16 , wherein said sugar is trehalose.
18. The process of claim 16 , wherein said sugar is a combination of trehalose and mannitol.
19. The process of claim 16 , wherein said aqueous medium mixture comprises at least 8% w/v of the sugar.
20. The process of claim 1 , wherein the sugar is trehalose and the binding-gel forming agent is hydroxypropylmethyl cellulose.
21. The process of the claim 20 , wherein the ratio of trehalose to hydroxypropylmethylcellulose is from 10:1 to 1:5.
22. The process of claim 1 , wherein said aqueous medium mixture is blended in the absence of gelatin.